Supernus Pharmaceuticals (S49.STU) Q3 2026 Earnings

3AugConfirmed
Q2 2026
Q3 2026
0.25
0.34
0.43
0.51

Details

Expected EPS
0.36711024999999997
Actual EPS
0.45709961629999996
Surprise EPS
0.09
Surprise Percent
+24.51%

Description

Supernus Pharmaceuticals (S49.STU) has reported earnings of 0.45709961629999996 per share for Q3 2026.

0 Comments

Share your thoughts